MINT-EPLERENONE
MINT PHARMACEUTICALS INC
Quick answers
Is there a shortage of MINT-EPLERENONE in Canada?
No. There is no current shortage of MINT-EPLERENONE 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-EPLERENONE
APOTEX INC
GD-EPLERENONE
GENMED A DIVISION OF PFIZER CANADA ULC
Other Products
INSPRA
BGP PHARMA ULC
JAMP EPLERENONE
JAMP PHARMA CORPORATION
MINT-EPLERENONE
MINT PHARMACEUTICALS INC
DIN
02471442
Strength
25MG
Dosage Form
Tablet
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
25MG · DIN 02468859
10MG · DIN 02468840
200MG · DIN 02524708
800MG · DIN 02524724
400MG · DIN 02524716
70.0MG · DIN 02394871
10MG · DIN 02362678
5MG · DIN 02362651
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430